Skip to content

13F-HR filed by First Turn Management, LLC

First Turn Management, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-06, with 34 holding rows worth $668,452,312.

Accession
0001085146-24-002247
Filed
2024-05-06
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, 34 entries on the cover page, a total value of $668,452,312 stated on the cover page (in dollars after the unit check, H1), rows summing to $668,452,312 with VALUE read as dollars as filed, 13F file number 028-23631. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SHOCKWAVE MED INC82489T104COM98,111$31,947,885dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR79,978$31,488,938dollars as filed
CYTOKINETICS INC23282W605COM NEW430,349$30,171,768dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock680,389$29,290,746dollars as filed
SAREPTA THERAPEUTICS INC803607100COM221,748$28,707,496dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock342,173$27,305,405dollars as filed
DEXCOM INC COM252131107Stock192,932$26,759,668dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR394,674$25,653,810dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock379,803$25,237,909dollars as filed
Vertex Pharmaceuticals Incorporated92532F100COM58,832$24,592,364dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM958,654$24,081,388dollars as filed
BIOHAVEN LTDG1110E107COM432,342$23,644,784dollars as filed
KRYSTAL BIOTECH INC COM501147102Stock130,850$23,282,140dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR151,587$22,915,407dollars as filed
TRANSMEDICS GROUP INC89377M109COM297,377$21,988,055dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock1,318,207$21,776,780dollars as filed
NUVALENT INC COM670703107Stock265,897$19,966,206dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock421,487$18,271,461dollars as filed
VAXCYTE INC COM92243G108Stock260,281$17,779,795dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW464,435$17,616,020dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock397,782$17,454,674dollars as filed
IMMUNOVANT INC45258J102COM512,893$16,571,573dollars as filed
DISC MEDICINE INC COM254604101Stock252,673$15,731,421dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS973,130$15,657,662dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM1,097,571$15,091,601dollars as filed
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK206,707$14,304,124dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM1,179,420$13,987,921dollars as filed
ALPHATEC HLDGS INC02081G201COM NEW990,618$13,660,622dollars as filed
LEGEND BIOTECH CORP52490G102SPONSORED ADS228,251$12,802,599dollars as filed
EYEPOINT INC COM NEW30233G209Stock585,447$12,101,189dollars as filed
VIKING THERAPEUTICS INC92686J106COM128,064$10,501,248dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM250,870$6,758,438dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK381,210$6,251,844dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK118,260$5,099,371dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-24-002247this filing2024-05-06acceptance time not in the bulk data set